P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2005

Features

Health Care and Law

Support Grows for a Third Class of "Behind-the-Counter” Drugs

Some think that it might be time to add a new class of drugs to the existing categories.
Robert I. Field, JD, MPH, PhD

Risk of Heart Failure with the Use of Thiazolidinediones within a Medicaid Population

Analyzing patients’ prescription and medical claims from a managed care organization, the authors evaluate the risk of heart failure after TZD therapy.
Fadia T. Shaya, PhD, MPH, James Y. Shin, PharmD, C. Daniel Mullins, PhD, Antoine C. El Khoury, PhD, and Howard Garber, MD, MPH

Drug Class Review

Proton Pump Inhibitors in the Management of Patients with Acid-Peptic Disorders: A Managed Care Perspective

Drs. McCarthy and Caspi describe the benefits and risks of intravenous and oral PPIs and the considerations regarding their inclusion on formularies.
Denis M. McCarthy, MD, PhD, MSc, and Alan Caspi, PhD, PharmD, MBA

Case Study

Using Technology to Expand Services: An Application of Satellite Distribution in the Pharmaceutical Market

The authors describe the use of telemedicine and telepharmacy to provide drug delivery to low-income, underserved segments of the population.
LoriAnn Collins, RPh, MBA, Charles J. Quigley, Jr., PhD, and Frank G. Bingham, Jr., EdD

Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain Part 1 Assessment

The authors illustrate their discussion of cancer-related and non–cancer-related pain in a pertinent case study with an emphasis on pharmacological management.
Daniel Bennett, MD, Allen W. Burton, MD, Scott Fishman, MD, Barry Fortner, PhD, Bill McCarberg, MD, Chris Miaskowski, PhD, RN, David B. Nash, MD, MBA, Marco Pappagallo, MD, Richard Payne, MD, James Ray, PharmD, Eugene R. Viscusi, MD, and Winston Wong, PharmD

Departments

Editorial

Relationship Guidance

David Nash, MD, MBA, summarizes one institution’s guidelines for relationships between employees in academic medicine and pharmaceutical sales representatives.
David Nash, MD, MBA

Medication Errors

Errors in the Making: Nearly Unreadable Labeling of Plastic Ampules for Nebulizing Agents

Matthew Grissinger, RPh, FASCP, discusses the increased risk of errors resulting from poorly labeled plastic ampules for nebulizing agents.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medical-Error Reporting Bill Starts Up the Mountain . . . Again

Stephen Barlas discusses the Safety and Quality Improvement Act of 2005, which is intended to help decrease medical errors.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Truvada™: A New Combination Therapy to Increase Compliance and Decrease Pill Burden in HIV-Infected Patients

The authors review the benefits of increased compliance and decreased pill burden with Truvada™ for treating HIV infection.
Evans Branch III, PharmD, Marlon Honeywell, PharmD, Wayne Simon, PharmD, Anishka Richardson, PharmD, and Muideen Adigun, PharmD Candidate